SCHEMBL22062710

SCHEMBL22062710

CC(C)c1cccc(-c2cc3c4c(c2)n2c5ccccc5nc2n4c2nc4ccccc4n32)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASR P41180 1/20 0.37
LMNA P02545 3/20 0.36
TSHR P16473 1/20 0.36
KDM4E B2RXH2 4/20 0.36
HPGD P15428 4/20 0.36
ALDH1A1 P00352 3/20 0.36
RXRA P19793 1/20 0.36
RXRB P28702 1/20 0.36
RXRG P48443 1/20 0.36
HSD17B10 Q99714 4/20 0.35
TP53 P04637 3/20 0.35
MAPT P10636 3/20 0.35
PTPN5 P54829 2/20 0.35
RAB9A P51151 2/20 0.35
ALPG P10696 1/20 0.35
GAA P10253 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
POLB P06746 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22063040 0.91 CASR (0.39) CASRLMNAKDM4EHPGDALDH1A1
SCHEMBL22063201 0.90 KDM4E (0.39) CASRLMNATSHRKDM4EHPGD
SCHEMBL22062534 0.87 CASR (0.46) CASRLMNAKDM4EHPGDALDH1A1
SCHEMBL22087374 0.85 KDM4E (0.33) CASRLMNATSHRKDM4EHPGD
SCHEMBL22063217 0.85 KDM4E (0.40) CASRLMNATSHRKDM4EHPGD
SCHEMBL22062533 0.84 ALDH1A1 (0.44) LMNAKDM4EHPGDALDH1A1HSD17B10
SCHEMBL22063333 0.83 CASR (0.37) CASRLMNATSHRKDM4EHPGD
SCHEMBL22063340 0.83 CASR (0.37) CASRLMNATSHRKDM4EHPGD
SCHEMBL22062709 0.83 TP53 (0.48) KDM4EHPGDALDH1A1HSD17B10TP53
SCHEMBL22063202 0.81 KDM4E (0.46) LMNAKDM4EHPGDALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200185620-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2020-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200185620-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE EMC2, NFE2L2, AOC2 CASR 3390/4885LMNA 1641/4885TSHR 3441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.